Biotech

All Articles

Lundbeck signs $2.5 B look for Longboard and its epilepsy med

.After spying blockbuster capacity in Longboard Pharmaceuticals' epilepsy med, brain disease-focused...

Lilly decides on UK for 1st Entrance Lab in Europe

.Eli Lilly's Entrance Labs is actually going global, along with the U.K. government introducing toda...

Jasper dials up dosage after colonies feedbacks come and go swiftly

.Jasper Therapy has actually disclosed full responses in 10 of the 12 chronic hives clients that acq...

Transgene's popular cancer injection flunks midphase test

.Transgene's curative vaccination candidate TG4001 has failed a period 2 sound growth trial. But, wh...

Upstream swells IPO to $255M as it lists alongside CAMP4

.Upstream Bio possesses inflamed its own IPO to $255 thousand as the company signs up with CAMP4 Reh...

Sanofi fails MS study, dealing yet another strike to Denali pact

.Sanofi has actually stopped a period 2 trial of Denali Therapeutics-partnered oditrasertib in vario...

Turnstone gives up 60%, agitates C-suite to extend cash

.Turnstone Biologics is lessening its head count by 60% and also shaking up its C-suite to always ke...

Gilead surrenders on $15M MASH wager after reviewing preclinical data

.In a year that has actually viewed an authorization as well as a range of readouts for metabolic dy...

Texas biotech centers cancer cells treaty, pins hopes on excessive weight

.Alaunos Therapeutics is axing a deal with Precigen, losing hope licensing civil liberties to a pers...

Capricor shares much more information for DMD therapy after starting BLA

.Capricor Therapeutics is taking a success tour for their period 2 Duchenne muscular dystrophy (DMD)...